New cholesterol drug put to the test in healthy volunteers
NCT ID NCT07152873
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This early-stage study tests a new drug for mixed dyslipidemia (high cholesterol and fats in the blood) in 60 healthy adults. Participants will receive two versions of the drug at different times to compare how the body absorbs and processes them. The goal is to gather safety and drug-level information before testing in patients with the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H Plus Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.